Literature DB >> 21878350

Minimal structural requirements of alkyl γ-lactones capable of antagonizing the cocaine-induced motility decrease in planarians.

Debra Baker1, Sean Deats, Peter Boor, James Pruitt, Oné R Pagán.   

Abstract

We recently reported that the natural cyclic lactone, parthenolide, and related analogs prevent the expression of behavioral effects induced by cocaine in planarians and that parthenolide's γ-lactone ring is required for this effect. In the present work, we tested a series of alkyl γ-lactones with varying chain length (1-8 carbons) to determine their ability to antagonize the planarian motility decrease induced by 200 μM cocaine. Alkyl lactones with up to a 4-carbon alkyl chain did not affect planarian motility or antagonized the cocaine-induced motility decrease; only the compound γ-nonalactone (a γ-lactone with a 5-carbon chain) was able to prevent the cocaine-induced behavioral patterns, while alkyl lactones with longer carbon chains failed to prevent the cocaine-induced effects. Thus, we conclude that the optimal structural features of this family of compounds to antagonize cocaine's effect in this experimental system is a γ-lactone ring with at a 5-carbon long functional group.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878350      PMCID: PMC3183103          DOI: 10.1016/j.pbb.2011.08.013

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  39 in total

Review 1.  Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels.

Authors:  A Scholz
Journal:  Br J Anaesth       Date:  2002-07       Impact factor: 9.166

2.  Opening a new can of worms: a large-scale RNAi screen in planarians.

Authors:  Phillip A Newmark
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

3.  Neural projections in planarian brain revealed by fluorescent dye tracing.

Authors:  Keiji Okamoto; Kosei Takeuchi; Kiyokazu Agata
Journal:  Zoolog Sci       Date:  2005-05       Impact factor: 0.931

Review 4.  Regenerating the central nervous system: how easy for planarians!

Authors:  Francesc Cebrià
Journal:  Dev Genes Evol       Date:  2007-11-13       Impact factor: 0.900

5.  A pharmacological study of cocaine activity in planaria.

Authors:  G Palladini; S Ruggeri; F Stocchi; M F De Pandis; G Venturini; V Margotta
Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol       Date:  1996-09

Review 6.  From cocaine to ropivacaine: the history of local anesthetic drugs.

Authors:  Y A Ruetsch; T Böni; A Borgeat
Journal:  Curr Top Med Chem       Date:  2001-08       Impact factor: 3.295

7.  A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms.

Authors:  Oné R Pagán; Amanda L Rowlands; Angela L Fattore; Tamara Coudron; Kimberly R Urban; Apurva H Bidja; Vesna A Eterović
Journal:  Eur J Pharmacol       Date:  2009-05-30       Impact factor: 4.432

8.  Reconstruction of dopaminergic neural network and locomotion function in planarian regenerates.

Authors:  Kaneyasu Nishimura; Yoshihisa Kitamura; Takeshi Inoue; Yoshihiko Umesono; Shozo Sano; Kanji Yoshimoto; Masatoshi Inden; Kazuyuki Takata; Takashi Taniguchi; Shun Shimohama; Kiyokazu Agata
Journal:  Dev Neurobiol       Date:  2007-07       Impact factor: 3.964

9.  SmedGD: the Schmidtea mediterranea genome database.

Authors:  Sofia M C Robb; Eric Ross; Alejandro Sánchez Alvarado
Journal:  Nucleic Acids Res       Date:  2007-09-18       Impact factor: 16.971

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  1 in total

1.  Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians.

Authors:  Christopher S Tallarida; Kristopher Bires; Jacob Avershal; Ronald J Tallarida; Stephanie Seo; Scott M Rawls
Journal:  Alcohol       Date:  2014-08-07       Impact factor: 2.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.